Development and validation of a prognostic nomogram for progression-free and overall survival in patients with advanced renal cell carcinoma (aRCC) treated with pazopanib.
Michael W. Kattan
Consultant or Advisory Role - GlaxoSmithKline; Merck; Novartis
Cora N. Sternberg
Honoraria - AstraZeneca; AVEO; Boehringer Ingelheim; GlaxoSmithKline; Pfizer
Faisal Mehmud
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Kamalnayan Bhatt
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Debasis Chakrabarti
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Lauren McCann
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Robert John Motzer
Consultant or Advisory Role - Pfizer
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Pfizer